General Information
BounceWatch is an independent company data service, not affiliated with Arphio. To contact Arphio, visit arphio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Arphio compare?
A PDF of Arphio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Arphio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Arphio on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Malta Market
Health Care
About Arphio
Business keywords: Rare diseases, Orphan pharmaceuticals, Patient access, Drug development, Global market access, Pharmaceutical professionals, Data science, Pharmaceutical data, Market intelligence, Therapeutics, Orphan drug supply, Healthcare industry, Diagnostic expertise
No funding data available for Arphio yet.
Arphio Alternatives & Competitors
View All AlternativesFocused on the research and development of therapeutics for infectious diseases and rare disorders
Komtur delivers comprehensive healthcare solutions that connect pharmaceutical innovations with pati...
Aceragen is a rare disease company striving to restore a better life for patients and families.
FAQ About Arphio
Source: BounceWatch company record for Arphio, https://www.bouncewatch.com/company/arphio, updated 11 May 2025. When citing, please name BounceWatch and link this page.